Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,968	2,963	1,354	1,114	955	905
Market Cap Growth	17.58%	118.80%	21.52%	16.65%	5.51%	-1.30%
Enterprise Value	2,272	3,327	1,279	1,080	913	883
PE Ratio	13.82	21.54	14.82	17.94	680.90	18.50
PS Ratio	2.86	4.60	2.71	2.55	2.73	2.81
PB Ratio	2.88	4.63	2.56	2.50	2.38	2.37
P/FCF Ratio	12.04	20.39	20.65	15.80	40.81	4374.08
P/OCF Ratio	9.76	16.15	15.19	11.37	16.68	21.68
EV/Sales Ratio	3.36	5.16	2.56	2.47	2.61	2.74
EV/EBITDA Ratio	9.13	14.76	8.88	9.90	30.99	10.65
EV/EBIT Ratio	10.36	16.93	10.96	12.91	171.69	14.06
EV/FCF Ratio	14.12	22.89	19.50	15.31	38.99	4263.50
Debt / Equity Ratio	0.93	0.98	0.19	0.23	0.17	0.17
Debt / EBITDA Ratio	2.52	2.77	0.71	0.96	2.28	0.80
Debt / FCF Ratio	3.90	4.29	1.56	1.48	2.87	321.86
Quick Ratio	1.69	1.66	2.81	2.10	1.57	1.50
Current Ratio	2.17	2.17	3.99	3.06	2.49	2.84
Asset Turnover	0.45	0.50	0.69	0.67	0.58	0.56
Interest Coverage	6.20	7.24	63.22	94.50	14.22	527.57
Return on Equity (ROE)	24.80%	23.20%	18.20%	14.60%	0.40%	13.10%
Return on Assets (ROA)	10.30%	10.60%	12.60%	9.40%	0.20%	8.40%
Return on Capital (ROIC)	13.70%	12.66%	13.55%	9.54%	0.66%	-0.01%
Earnings Yield	7.99%	4.64%	6.75%	5.57%	0.15%	5.41%
FCF Yield	8.31%	4.90%	4.84%	6.33%	2.45%	0.02%
Buyback Yield / Dilution	-2.01%	-1.09%	-5.31%	-1.34%	1.57%	-7.57%
Total Shareholder Return	-2.01%	-1.09%	-5.31%	-1.34%	1.57%	-7.57%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).